Results 81 to 90 of about 584,756 (169)

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.

JAMA Oncol
Socinski MA, Stahel R, Lee DH, Cappuzzo F, Nishio M, Lovly CM, Ozyilkan O, Li Q, Johnson M, Garon EB, Kilickap S, Ferreira da Silva FA, Alatorre-Alexander J, Meng R, Amin R, Matheny C, Troutman S, Wen X, Patil NS, Zou W, Rodriguez-Abreu D.   +20 more
europepmc   +1 more source

Helium Plasma Radiofrequency for Aesthetic Subdermal Treatment: A Systematic Review and Meta-Analysis. [PDF]

Aesthet Surg J Open Forum
Shridharani SM, Sterodimas A, Harsch MR, Larson KA.   +3 more
europepmc   +1 more source

Correction: Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID‑19 Vaccination During Pregnancy. [PDF]

Drug Saf
Coates MM, Rowe SL, Sullivan SG, Munoz FM, Arah OA, Regan AK.   +5 more
europepmc   +1 more source

Setting Yourself up for Success as an Early Career Investigator in Clinical Trials. [PDF]

JACC Adv
Bharadwaj AS, Reza N, Wiggins N, Rymer J, Cader FA, Mehran R.   +5 more
europepmc   +1 more source

Community-Based Interventions for Initiating Early End-of-Life Conversations in Nonterminally Ill Adults: A Systematic Review. [PDF]

Campbell Syst Rev
Tan YY, Fu S, Fong KY, Miny S, Foong PS, Chan Guek NC, Koh GCH, Lim MJR.   +7 more
europepmc   +1 more source

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial. [PDF]

Eur Stroke J
Maes L, Verschuere C, Walsh C, Weimar C, Purroy F, Price C, Fonseca C, Hill MD, Jatuzis D, Kõrv J, Kruuse C, Mikulik R, Nederkoorn P, Czlonkowska A, Fischer U, McCormick M, Castellanos M, Baptista M, Marto JP, Thavanesan K, Williams DJ, Kelly P, Lemmens R, CONVINCE investigators .   +23 more
europepmc   +1 more source

TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with <i>EGFR</i>-mutated locally advanced or metastatic non-small cell lung cancer. [PDF]

Ther Adv Med Oncol
Lu S, Pulla MP, Mascarenhas E, Tanizaki J, Kim HR, Liu Y, Feng S, Zhang B, Toms L, Yang JC, Goldberg SB.   +10 more
europepmc   +1 more source

Prophylactic tranexamic acid for the prevention of postpartum haemorrhage in women with placenta praevia: multicentre, double blind, randomised, placebo controlled, phase 3 trial.

BMJ
Zhang L, Bi S, Chen L, Du L, He F, Qiao Y, Li Z, Zeng W, Zhao X, Chen X, Li X, Ding G, Zhou W, Sun B, Guo Q, Guo X, Jin F, Wang X, Zhu Q, Sun Q, Jiang S, Wang X, Cai F, Jiang Y, Gao J, Wang Z, Wang Z, Zhang L, Liu JM, Huang L, Yu L, Chen J, Zhang S, Poon LC, Li HT, Chen D, study’s collaborator group.   +36 more
europepmc   +1 more source

Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years. [PDF]

Breast
Bonomi G, Napetti D, Griguolo G, Zanghì F, Girardi F, Lando S, Napolitano P, Landa G, La Commare M, Massa D, Guarneri V, Dieci MV.   +11 more
europepmc   +1 more source